Clorox vs Coty
CLX and COTY side by side, both in soap, detergents, and cleaning preparations; perfumes, cosmetics, and other toilet preparations. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CLX and COTY compare
Clorox is the larger company, worth 3.6 times as much as Coty ($10.6B against $3.0B).
Coty grew revenue faster over the last twelve months (−1.5% versus −5.4% for Clorox).
Clorox keeps more of each dollar of sales as profit, with a net margin of 8.7% compared with −10.4% at Coty.
Clorox pays a dividend yielding 4.2%; Coty does not pay one.
Clorox scores higher on the StockData Score (14 against 4 for Coty), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CLX | COTY |
|---|---|---|
| Size and price | ||
| Market cap | $10.6B | $3.0B |
| Share price | $88.00 | $3.40 |
| Change, 1 year | −20.5% | −13.9% |
| Change, 5 years | −46.1% | −63.4% |
| Beta (5Y) | 0.53 | 1.05 |
| Employees | 9,200 | 11K |
| StockData Score | ||
| Total score | 14 (better) | 4 |
| Valuation score | 5 (better) | 3 |
| Growth score | 2 (better) | 0 |
| Performance score | 4 (better) | 0 |
| Health score | 0 | 1 (better) |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 18.3× | – |
| P/S | 1.6× | 0.5× (better) |
| P/B | 118× | 1.0× (better) |
| EV/EBITDA | 13.5× (better) | 15.1× |
| P/FCF | 26.3× | 8.6× (better) |
| PEG | 0.31 | – |
| FCF yield | 3.8% | 11.6% (better) |
| Fair value | $143.34 | $4.42 |
| Margin of safety | 38.6% (better) | 23.2% |
| Growth | ||
| Revenue growth (TTM) | −5.4% | −1.5% (better) |
| Revenue growth, 5Y average | −1.8% | 4.6% (better) |
| Net income growth (TTM) | −27.5% | – |
| EPS growth (TTM) | −26.2% | – |
| EPS growth, 5Y average | −2.9% | – |
| Profitability | ||
| Gross margin | 42.3% | 62.9% (better) |
| Operating margin | – | −1.4% |
| Net margin | 8.7% (better) | −10.4% |
| FCF margin | 6.0% (better) | 6.0% |
| Return on equity | 286% (better) | −18.5% |
| Return on invested capital | – | −0.98% |
| Financial health | ||
| Debt / equity | 56.31 | 1.02 (better) |
| Net debt / EBITDA | 4.22 (better) | 7.17 |
| Interest coverage | – | −0.4× |
| Current ratio | 0.66 | 0.75 (better) |
| Altman Z-score | 1.63 (better) | −0.07 |
| Piotroski F-score | 3 | 3 |
| Dividends and buybacks | ||
| Dividend yield | 4.2% | – |
| Payout ratio | 103% | – |
| Years of dividend growth | 17 | – |
| Dividend growth, 5Y average | 2.2% | – |
| Buyback yield | 2.4% | – |
| Shareholder yield | 6.6% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 86.3% | 44.1% |
| Held by insiders | 0.65% | 61.5% |
| Insider net buying, 12 months | $846K (better) | $213K |
| Superinvestors holding | 2 (better) | 1 |
| Short interest, % of float | 9.6% | 12.0% |
Go deeper
- CLX stock overview
- CLX income statement
- CLX valuation and score
- COTY stock overview
- COTY income statement
- COTY valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.